Comprehensive Formulary

Use the links below to access the Oklahoma Dual Complete Comprehensive and Abridged Formularies.


Abridged Formulary

Important Message About What You Pay for Vaccines - Our plan covers most Part D vaccines at no cost to you. Call Customer Services for more information.

Important Message About What You Pay for Insulin – You won’t pay more than $35 for a one-month supply of each insulin product covered by our plan, no matter what cost-sharing tier it’s on.

Part B Rebatable Drug Coinsurance Adjustment

Effective April 1, 2023, certain Medicare Part B drugs may have a lower coinsurance than what is stated in a member’s benefit documents. Members may pay a lower coinsurance if the price of the drug is rising faster than the rate of inflation. The Centers for Medicare & Medicaid Services (CMS) makes the determination on which Part B drugs qualify for the lower coinsurance and the coinsurance adjustment amount. CMS has the right to review and change this list of drugs up to 4 times a year. The Rebatable Drug Coinsurance Adjustment will occur through an enrollee refund if the mandatory reduction occurs after claims have been processed in 2024.

Part B Insulin Cost Sharing Cap

Starting July 1, 2023, Medicare Advantage plans must cover Part B insulin for use in insulin pumps at the copayment and coinsurance cap of $35 for a one-month supply of insulin.


Extended Day Supply for Oklahoma Dual Complete members on Tier 1 medications (100 days or more)

Enjoy the convenience of extended supplies on select Tier 1 medications (100 days or more) and pay $0 copay.


Formulary Changes and Utilization Management Criteria

2025 Senior Health Plan Utilization Management Criteria Documents
  Formulary Changes Prior Authorization Step Therapy Quantity Limits
JanuaryN/AJanuary 2025 Prior Authorization Criteriacoming soonJanuary 2025 Step Therapycoming soonSee comprehensive formulary for quantity limits.

HPMS Formulary ID: 00025283 Version 7
HPMS Formulary Approval Date: 08/26/2023
Updated: 01/2025



Files will open in a new window and require Acrobat Reader to view.